{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:44:28Z","timestamp":1790948668218,"version":"4.1.0"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017584","name":"SRM Institute of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017584","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ijbiomac.2022.09.116","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T23:28:40Z","timestamp":1663284520000},"page":"1464-1479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Pulmonary drug delivery applications of natural polysaccharide polymer derived nano\/micro-carrier systems: A review"],"prefix":"10.1016","volume":"220","author":[{"given":"Akshad","family":"Balde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se-Kwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soottawat","family":"Benjakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasool Abdul","family":"Nazeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10053","key":"10.1016\/j.ijbiomac.2022.09.116_bb0005","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132015: a systematic analysis for the global burden of disease study 2015","volume":"388","author":"Forouzanfar","year":"2016","journal-title":"Lancet"},{"issue":"10082","key":"10.1016\/j.ijbiomac.2022.09.116_bb0010","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(17)30505-6","article-title":"Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the global burden of diseases study 2015","volume":"389","author":"Cohen","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.09.116_bb0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1470-2045(02)00815-X","article-title":"Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention","volume":"3","author":"Hecht","year":"2002","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.09.116_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233147","article-title":"Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and metaanalysis","volume":"15","author":"Alqahtani","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5339\/gcsp.2015.2","article-title":"Inhaled nano- and microparticles for drug delivery","volume":"2015","author":"El-Sherbiny","year":"2015","journal-title":"Glob. Cardiol. Sci. Pract."},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.09.116_bb0030","doi-asserted-by":"crossref","first-page":"1700513","DOI":"10.1002\/advs.201700513","article-title":"Polysaccharide-based controlled release systems for therapeutics delivery and tissue engineering: from bench to bedside","volume":"5","author":"Miao","year":"2018","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.09.116_bb0040","first-page":"685","article-title":"Evolution from small molecule to nano-drug delivery systems: an emerging approach for cancer therapy of ursolic acid","volume":"15","author":"Shao","year":"2020","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0045","series-title":"Natural Polymer Drug Delivery Systems","first-page":"33","article-title":"Nanoparticles types, classification, characterization, fabrication methods and drug delivery applications","author":"Bhatia","year":"2016"},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.09.116_bb0050","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1080\/10962247.2020.1727588","article-title":"Preparation and optimization of chitosan nanoparticles from discarded squilla (Carinosquilla multicarinata) shells for the delivery of anti-inflammatory drug: diclofenac","volume":"70","author":"Balde","year":"2020","journal-title":"J. Air Waste Manag. Assoc."},{"issue":"100397","key":"10.1016\/j.ijbiomac.2022.09.116_bb0055","article-title":"Recent developments in functionalized polymer nanoparticles for efficient drug delivery system","volume":"20","author":"Sur","year":"2019","journal-title":"Nano-struct. Nano-objects"},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0060","article-title":"Perspectives on important considerations in designing nanoparticles for oral delivery applications in food","volume":"2","author":"Luo","year":"2020","journal-title":"J. Agric. Food Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0065","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13569","article-title":"Pacific white shrimp (Litopenaeus vannamei) shell chitosan and the conjugate with epigallocatechin gallate: antioxidative and antimicrobial activities","volume":"45","author":"Mittal","year":"2021","journal-title":"J. Food Biochem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.09.116_bb0070","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1007\/s10989-021-10276-y","article-title":"Crab pentapeptide and its anti-inflammatory activity on macrophage cells","volume":"27","author":"Balde","year":"2021","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"107140","key":"10.1016\/j.ijbiomac.2022.09.116_bb0075","article-title":"A Meretrix meretrix visceral mass derived peptide inhibits lipopolysaccharide-stimulated responses in RAW264.7 cells and adult zebrafish model","volume":"90","author":"Joshi","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.09.116_bb0080","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3390\/molecules27020473","article-title":"Chitosan nanoparticle-based system: a new insight into the promising controlled release system for lung cancer treatment","volume":"27","author":"Yee Kuen","year":"2022","journal-title":"Molecules"},{"issue":"117149","key":"10.1016\/j.ijbiomac.2022.09.116_bb0085","article-title":"Dry powders containing chitosan-based nanocapsules for pulmonary administration: Adjustment of spraydrying process and in vitro evaluation in A549 cells","volume":"399","author":"Fernandez-Paz","year":"2022","journal-title":"Powder Technol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.09.116_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01684","article-title":"Degradability of chitosan micro\/nanoparticles for pulmonary drug delivery","volume":"5","author":"Islam","year":"2019","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano baseddrug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.carbpol.2010.10.062","article-title":"Biological activities and potential health benefits of sulfated polysaccharides derived from marine algae","volume":"84","author":"Wijesekara","year":"2011","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0105","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.drudis.2019.09.023","article-title":"Physicochemical properties affecting the fate of nanoparticles in pulmonary drug delivery","volume":"25","author":"Liu","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.indcrop.2020.112679","article-title":"A new approach in the hydrophobic modification of polysaccharide-based edible films using structured oil nanoparticles","volume":"154","author":"Ghiasi","year":"2020","journal-title":"Ind. Crop. Prod."},{"issue":"667","key":"10.1016\/j.ijbiomac.2022.09.116_bb0115","first-page":"204","article-title":"Dehydrated chitosan nanoparticles","volume":"12","author":"Kjems","year":"2011","journal-title":"uS Patent App."},{"issue":"980","key":"10.1016\/j.ijbiomac.2022.09.116_bb0120","first-page":"775","article-title":"Chitosan-based nanoparticles and methods for making and using the same","volume":"12","author":"Santra","year":"2011","journal-title":"uS Patent App."},{"issue":"13","key":"10.1016\/j.ijbiomac.2022.09.116_bb0125","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1042\/CS20160487","article-title":"Cellular and molecular mechanisms of asthma and COPD","volume":"131","author":"Barnes","year":"2017","journal-title":"Clin. Sci. (Lond.)"},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.09.116_bb0130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/oem.60.4.237","article-title":"Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence","volume":"60","author":"Hnizdo","year":"2003","journal-title":"Occup. Environ. Med."},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.09.116_bb0135","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/thx.2004.035170","article-title":"Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease","volume":"60","author":"Matheson","year":"2005","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.09.116_bb0140","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1378\/chest.09-1909","article-title":"Cigarette smoking as a cause of cancers other than lung cancer: an exploratory study using the surveillance, epidemiology, and end results program","volume":"138","author":"Ray","year":"2010","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease","volume":"138","author":"Barnes","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.09.116_bb0150","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/14728222.2019.1615884","article-title":"Molecular links between COPD and lung cancer: new targets for drug discovery?","volume":"23","author":"Caramori","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.09.116_bb0155","doi-asserted-by":"crossref","first-page":"288","DOI":"10.18433\/J3NC79","article-title":"Intranasal drug delivery: how, why and what for?","volume":"12","author":"Pires","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"s4","key":"10.1016\/j.ijbiomac.2022.09.116_bb0160","first-page":"S192","article-title":"Nasal delivery of antimigraine drugs: clinical rationale and evidence base","volume":"4","author":"Rapoport","year":"2006","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.09.116_bb0165","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/rmed.2002.1457","article-title":"Fundamentals of pulmonary drug delivery","volume":"97","author":"Groneberg","year":"2003","journal-title":"Respir. Med."},{"issue":"6 Pt 2","key":"10.1016\/j.ijbiomac.2022.09.116_bb0170","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/0091-6749(89)90162-0","article-title":"Mast cell stabilizers, anticholinergics, corticosteroids, and troleandomycin","volume":"84","author":"Wynn","year":"1989","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1 Suppl","key":"10.1016\/j.ijbiomac.2022.09.116_bb0175","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1067\/mai.2001.115564","article-title":"Effects of intranasal corticosteroids on the hypothalamicpituitary-adrenal axis in children","volume":"108","author":"Boner","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.09.116_bb0180","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaip.2018.01.025","article-title":"Inhaled corticosteroids safety and adverse effects in patients with asthma","volume":"6","author":"Heffler","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.09.116_bb0185","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jpeds.2014.09.055","article-title":"Inhaled corticosteroids and growth: still an issue after all these years","volume":"166","author":"Allen","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0190","series-title":"Allergy and Asthma","first-page":"569","article-title":"Antihistamines and mast cell stabilizers","author":"Codispoti","year":"2016"},{"issue":"101851","key":"10.1016\/j.ijbiomac.2022.09.116_bb0195","article-title":"Comparison of antiinflammatory mechanisms between doxofylline and theophylline in human monocytes","volume":"59","author":"Talmon","year":"2019","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.09.116_bb0200","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.arbres.2015.02.021","article-title":"Chronic use of theophylline and mortality in chronic obstructive pulmonary disease: a meta-analysis","volume":"52","author":"Horita","year":"2016","journal-title":"Arch. Bronconeumol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.09.116_bb0205","first-page":"93","article-title":"Comparative antiallergic effects of secondgeneration h1-antihistamines ebastine, cetirizine and loratadine in preclinical models","volume":"53","author":"Llupia","year":"2003","journal-title":"Arzneimittelforschung"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.09.116_bb0210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3345\/kjp.2018.07185","article-title":"Surfactant preparations for preterm infants with respiratory distress syndrome: past, present, and future","volume":"62","author":"Jeon","year":"2019","journal-title":"Korean J. Pediatr."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0215","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S2213-2600(19)30276-0","article-title":"Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI pooled cohorts study","volume":"8","author":"Oelsner","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"106096","key":"10.1016\/j.ijbiomac.2022.09.116_bb0220","article-title":"Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID19 outcomes: a systematic review and meta-analysis","volume":"171","author":"Sanchez-Ramirez","year":"2020","journal-title":"Respir. Med."},{"issue":"6965","key":"10.1016\/j.ijbiomac.2022.09.116_bb0225","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.09.116_bb0230","doi-asserted-by":"crossref","first-page":"2002108","DOI":"10.1183\/13993003.02108-2020","article-title":"COVID-19 and COPD","volume":"56","author":"Leung","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.09.116_bb0235","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"101770","key":"10.1016\/j.ijbiomac.2022.09.116_bb0240","article-title":"Isolation and characterization of angiotensin i-converting enzyme (ACE-I) inhibition and antioxidant peptide from by-catch shrimp (Oratosquilla woodmasoni) waste","volume":"29","author":"Joshi","year":"2020","journal-title":"Biocatal. Agric. Biotechnol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.09.116_bb0245","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/1061186X.2021.1971236","article-title":"Characteristics of SARS-CoV2 that may be useful for nanoparticle pulmonary drug delivery","volume":"30","author":"Rabiei","year":"2022","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0250","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-3659(02)00370-X","article-title":"Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features","volume":"86","author":"Dailey","year":"2003","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0255","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejpb.2011.12.014","article-title":"Crosslinked chitosan nanoparticle formulations for delivery from pressurized metered dose inhalers","volume":"81","author":"Sharma","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0260","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.powtec.2020.02.028","article-title":"Carbohydrate-based trojan microparticles as carriers for pulmonary delivery of lipid nanocapsules using dry powder inhalation","volume":"364","author":"Umerska","year":"2020","journal-title":"Powder Technol."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0265","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijbiomac.2019.06.058","article-title":"Losartan-chitosan\/dextran sulfate microplex as a carrier to lung therapeutics: dry powder inhalation, aerodynamic profile and pulmonary tolerability","volume":"136","author":"Elmowafy","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.09.116_bb0270","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tibtech.2007.09.005","article-title":"Nanoparticles for drug delivery to the lungs","volume":"25","author":"Sung","year":"2007","journal-title":"Trends Biotechnol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.09.116_bb0275","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1166\/jbn.2007.015","article-title":"Nanoparticles: characteristics, mechanisms of action, and toxicity in pulmonary drug delivery\u2014a review","volume":"3","author":"Gill","year":"2007","journal-title":"J. Biomed. Nanotechnol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0280","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/med.20140","article-title":"Nanoparticle formulations in pulmonary drug delivery","volume":"29","author":"Bailey","year":"2009","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0285","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.coi.2015.06.013","article-title":"Macrophage engulfment of a cell or nanoparticle is regulated by unavoidable opsonization, a species-specific \u2018marker of self\u2019 CD47, and target physical properties","volume":"35","author":"Sosale","year":"2015","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0290","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-3155-2-12","article-title":"Nanoparticles - known and unknown health risks","volume":"2","author":"Hoet","year":"2004","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.09.116_bb0295","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1166\/jbn.2006.031","article-title":"Biophysical investigation of nanoparticle interactions with lung surfactant model systems","volume":"2","author":"Stuart","year":"2006","journal-title":"J. Biomed. Nanotechnol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2022.09.116_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040775","article-title":"The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles","volume":"7","author":"Ruge","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.09.116_bb0305","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.09.116_bb0310","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s11095-008-9562-y","article-title":"Role of particle size in phagocytosis of polymeric microspheres","volume":"25","author":"Champion","year":"2008","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics4010001","article-title":"Trojan microparticles for drug delivery","volume":"4","author":"Anton","year":"2012","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.ijbiomac.2022.09.116_bb0320","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1002\/pat.4375","article-title":"Overview on natural hydrophilic polysaccharide polymers in drug delivery","volume":"29","author":"Abedini","year":"2018","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0325","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.addr.2017.10.009","article-title":"The role of mucus on drug transport and its potential to affect therapeutic outcomes","volume":"124","author":"Murgia","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"19","key":"10.1016\/j.ijbiomac.2022.09.116_bb0330","doi-asserted-by":"crossref","first-page":"11324","DOI":"10.1039\/C7NJ01808H","article-title":"Zn2+cross-linked sodium alginate-g-allylamine-mannose polymeric carrier of rifampicin for macrophage targeting tuberculosis nanotherapy","volume":"41","author":"Praphakar","year":"2017","journal-title":"New J. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.09.116_bb0335","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1080\/21691401.2016.1260578","article-title":"Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics","volume":"45","author":"Wang","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0340","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejpb.2013.09.006","article-title":"Real-time in vivo imaging of surface-modified liposomes to evaluate their behavior after pulmonary administration","volume":"86","author":"Murata","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0345","article-title":"Chitosan, chitooligosaccharides and their polyphenol conjugates: preparation, bioactivities, functionalities and applications in food systems","volume":"1\u201323","author":"Singh","year":"2021","journal-title":"Food Rev. Int."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0350","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijbiomac.2022.05.131","article-title":"Crab (Charybdis natator) exoskeleton derived chitosan nanoparticles for the in vivo delivery of poorly water-soluble drug: ibuprofen","volume":"212","author":"Balde","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0355","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0144-8617(00)00200-9","article-title":"Antimicrobial effect of chitooligosaccharides produced by bioreactor","volume":"44","author":"Jeon","year":"2001","journal-title":"Carbohydr. Polym."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.09.116_bb0360","doi-asserted-by":"crossref","first-page":"473","DOI":"10.5455\/jabet.2022.d129","article-title":"Extraction of squilla (Harpiosquilla annandalei) shell derived chitosan and its nanocarrier efficiency for sustained protein delivery","volume":"5","author":"Balde","year":"2022","journal-title":"J. Adv. Biotechnol. Exp. Ther."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2022.09.116_bb0365","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijpharm.2013.07.034","article-title":"Chitosan nanoparticles: preparation, size evolution and stability","volume":"455","author":"Rampino","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0370","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijbiomac.2021.02.216","article-title":"Chitosan-based nanocarriers for encapsulation and delivery of curcumin: a review","volume":"179","author":"Hu","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"30","key":"10.1016\/j.ijbiomac.2022.09.116_bb0375","doi-asserted-by":"crossref","first-page":"14341","DOI":"10.1039\/C6NR03256G","article-title":"Recent advances in chitosan-based nanoparticulate pulmonary drug delivery","volume":"8","author":"Islam","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0380","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijbiomac.2021.06.035","article-title":"Role of chitosanbased nanomedicines in the treatment of chronic respiratory diseases","volume":"185","author":"Gulati","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0385","article-title":"Chitosan-based oral colon-specific delivery systems for polyphenols: recent advances and emerging trends","author":"Chen","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0390","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijbiomac.2020.02.079","article-title":"Biodistribution and pharmacokinetics of thiolated chitosan nanoparticles for oral delivery of insulin in vivo","volume":"150","author":"Sudhakar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0395","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijbiomac.2020.09.163","article-title":"Mannose-anchored n, n, n-trimethyl chitosan nanoparticles for pulmonary administration of etofylline","volume":"165","author":"Pardeshi","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0400","first-page":"861","article-title":"Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery","volume":"7","author":"Sinsuebpol","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.09.116_bb0405","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1208\/s12249-018-0972-9","article-title":"Development of novel octanoyl chitosan nanoparticles for improved rifampicin pulmonary delivery: optimization by factorial design","volume":"19","author":"Petkar","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0410","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.ijbiomac.2018.04.147","article-title":"Chitosan-alginate nano-carrier for transdermal delivery of pirfenidone in idiopathic pulmonary fibrosis","volume":"118","author":"Abnoos","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0415","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejps.2016.12.013","article-title":"Nanocrystals embedded in chitosan-based respirable swellable microparticles as dry powder for sustained pulmonary drug delivery","volume":"99","author":"Ni","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.09.116_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/polym12051101","article-title":"Effect of poly-(vinyl alcohol) on nanoencapsulation of budesonide in chitosan nanoparticles via ionic gelation and its improved bioavailability","volume":"12","author":"Michailidou","year":"2020","journal-title":"Polymers (Basel)"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.09.116_bb0425","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s13346-019-00705-3","article-title":"Rifampicin loaded in alginate\/chitosan nanoparticles as a promising pulmonary carrier against staphylococcus aureus","volume":"10","author":"Scolari","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111309","article-title":"Food colloids binary and ternary nanocomplexes: innovations and discoveries","volume":"196","author":"Luo","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.09.116_bb0435","first-page":"280","article-title":"Alginate and alginate composites for biomedical applications","volume":"16","author":"Ahmad Raus","year":"2021","journal-title":"AsianJ. Pharm. Sci."},{"issue":"11","key":"10.1016\/j.ijbiomac.2022.09.116_bb0440","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13455","article-title":"Stability of tuna trypsin-loaded alginate-chitosan beads in acidic stomach fluid and the release of active enzyme in a simulated intestinal tract environment","volume":"44","author":"Buamard","year":"2020","journal-title":"J. Food Biochem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.09.116_bb0445","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3109\/10837450.2015.1081613","article-title":"Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation","volume":"21","author":"Garg","year":"2016","journal-title":"Pharm. Dev. Technol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.09.116_bb0450","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biologicals.2015.02.001","article-title":"Alginate microparticles loaded with lipopolysaccharide subunit antigen for mucosal vaccination against Klebsiella pneumoniae","volume":"43","author":"Jain","year":"2015","journal-title":"Biologicals"},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0455","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ijbiomac.2020.03.167","article-title":"Preparation and evaluation of alginate nanoparticles prepared by green method for drug delivery applications","volume":"154","author":"Thomas","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/7697031","article-title":"Alginate: current use and future perspectives in pharmaceutical and biomedical applications","volume":"2016","author":"Szekalska","year":"2016","journal-title":"Int. J. Polym. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.09.116_bb0465","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jbm.b.31570","article-title":"Role of protein contaminants in the immunogenicity of alginates","volume":"93","author":"Menard","year":"2010","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"issue":"20","key":"10.1016\/j.ijbiomac.2022.09.116_bb0470","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.3390\/ijms20205092","article-title":"Natural polysaccharide nanomaterials: an overview of their immunological properties","volume":"20","author":"Torres","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0475","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/mutage\/gew035","article-title":"Genotoxic and inflammatory effects of nanofibrillated cellulose in murine lungs","volume":"32","author":"Catalan","year":"2017","journal-title":"Mutagenesis"},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0480","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.toxlet.2018.04.013","article-title":"Evaluating the genotoxicity of cellulose nanofibrils in a co-culture of human lung epithelial cells and monocyte-derived macrophages","volume":"291","author":"Ventura","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0485","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jddst.2018.06.004","article-title":"Synthesis and in vitro evaluation of alginate-cellulose nanocrystal hybrid nanoparticles for the controlled oral delivery of rifampicin","volume":"46","author":"Thomas","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0490","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.colsurfb.2014.11.037","article-title":"Effect of polymer molecular weight on chitosan-protein interaction","volume":"125","author":"Bekale","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.09.116_bb0495","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1166\/jnn.2007.609","article-title":"Insulin-loaded nanoparticles are prepared by alginate ionotropic pregelation followed by chitosan polyelectrolyte complexation","volume":"7","author":"Sarmento","year":"2007","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.09.116_bb0500","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.carbpol.2009.02.019","article-title":"Evaluation of Alginate\/Chitosan nanoparticles as antisense delivery vector: formulation, optimization and in vitro characterization","volume":"77","author":"Gazori","year":"2009","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0505","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s41598-020-57666-8","article-title":"Characterization of chitosan\/alginate\/lovastatin nanoparticles and investigation of their toxic effects in vitro and in vivo","volume":"10","author":"Thai","year":"2020","journal-title":"Sci. Rep."},{"issue":"101292","key":"10.1016\/j.ijbiomac.2022.09.116_bb0510","article-title":"Lapazine loaded Alginate\/Chitosan microparticles: Enhancement of anti-mycobacterium activity","volume":"54","author":"Longuinho","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.09.116_bb0515","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.bej.2008.01.021","article-title":"Production of hyaluronic acid by repeated batch fermentation","volume":"40","author":"Huang","year":"2008","journal-title":"Biochem. Eng. J."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0520","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.supflu.2019.04.013","article-title":"Alginate and hybrid alginate-hyaluronic acid aerogel microspheres as potential carrier for pulmonary drug delivery","volume":"150","author":"Athamneh","year":"2019","journal-title":"J. Supercrit. Fluids"},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0525","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.indcrop.2015.11.082","article-title":"Cellulose nanocrystals extracted from rice husks as a reinforcing material in gelatin hydrogels for use in controlled drug delivery systems","volume":"93","author":"Ooi","year":"2016","journal-title":"Ind. Crop. Prod."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.09.116_bb0530","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.colsurfb.2011.02.039","article-title":"Effect of polysaccharide nanocrystals on structure, properties, and drug release kinetics of alginate-based microspheres","volume":"85","author":"Lin","year":"2011","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0535","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijpharm.2019.05.035","article-title":"Fabrication of bioactive rifampicin loaded \u03ba-CarMA-INH\/Nano hydroxyapatite composite for tuberculosis osteomyelitis infected tissue regeneration","volume":"565","author":"Amarnath Praphakar","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117999","article-title":"Recent advances in dextran-based drug delivery systems: from fabrication strategies to applications","volume":"264","author":"Hu","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.09.116_bb0545","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1128\/AAC.35.12.2544","article-title":"Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection","volume":"35","author":"Flexner","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.ijbiomac.2022.09.116_bb0550","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1021\/acs.molpharmaceut.6b00532","article-title":"Permeability profiles and intestinal toxicity assessment of hydrochlorothiazide and its inclusion complex with \u03b2-cyclodextrin loaded into chitosan nanoparticles","volume":"13","author":"Onnainty","year":"2016","journal-title":"Mol. Pharm."},{"issue":"5761","key":"10.1016\/j.ijbiomac.2022.09.116_bb0555","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.1114397","article-title":"Toxic potential of materials at the nanolevel","volume":"311","author":"Nel","year":"2006","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.09.116_bb0560","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/jam.2005.18.137","article-title":"Cell culture models of the respiratory tract relevant to pulmonary drug delivery","volume":"18","author":"Steimer","year":"2005","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0565","series-title":"Chemistry and biology of hyaluronan","first-page":"71","article-title":"Biodegradation of hyaluronan","author":"Lepperdinger","year":"2004"},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118784","article-title":"Polysaccharide-based formulations as potential carriers for pulmonary delivery\u2013a review of their properties and fates","volume":"277","author":"Valente","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0575","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejps.2018.08.038","article-title":"Chitosan nanoparticles as a promising approach for pulmonary delivery of bedaquiline","volume":"124","author":"Rawal","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0580","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijpharm.2019.03.051","article-title":"Alginate lyase immobilized chitosan nanoparticles of ciprofloxacin for the improved antimicrobial activity against the biofilm associated mucoid P. aeruginosa infection in cystic fibrosis","volume":"563","author":"Patel","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0585","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.vetimm.2018.04.006","article-title":"Nasal delivery of chitosan\/alginate nanoparticle encapsulated bee (Apis mellifera) venom promotes antibody production and viral clearance during porcine reproductive and respiratory syndrome virus infection by modulating T cell related responses","volume":"200","author":"Lee","year":"2018","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0590","doi-asserted-by":"crossref","first-page":"26269","DOI":"10.1038\/srep26269","article-title":"Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes","volume":"6","author":"Qie","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0595","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejpb.2020.02.010","article-title":"Converting nanosuspension into inhalable and redispersible nanoparticles by combined in-situ thermal gelation and spray drying","volume":"149","author":"Wan","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0600","first-page":"1","article-title":"Encapsulation and delivery of bioactive compounds using spray and freeze-drying techniques: a review","author":"Rezvankhah","year":"2019","journal-title":"Dry. Technol."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0605","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijbiomac.2019.11.190","article-title":"Development of chitosan-coated liposome for pulmonary delivery of n-acetylcysteine","volume":"156","author":"Hamedinasab","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.09.116_bb0610","first-page":"374","article-title":"Critical physicochemical attributes of chitosan nanoparticles admixed lactose-PEG 3000 microparticles in pulmonary inhalation","volume":"15","author":"Alhajj","year":"2020","journal-title":"Asian J. Pharm. Sci."},{"issue":"118578","key":"10.1016\/j.ijbiomac.2022.09.116_bb0615","article-title":"In vitro antibacterial activity of ciprofloxacin loaded chitosan microparticles and their effects on human lung epithelial cells","volume":"569","author":"Kucukoglu","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.09.116_bb0620","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1080\/03639045.2019.1608231","article-title":"Inhalable chitosan microparticles for simultaneous delivery of isoniazid and rifabutin in lung tuberculosis treatment","volume":"45","author":"Cunha","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.09.116_bb0625","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1089\/jamp.2018.1460","article-title":"Pulmonary delivery of isoniazid in nanogel-loaded chitosan hybrid microparticles for inhalation","volume":"32","author":"Omar","year":"2019","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190976","article-title":"Development and evaluation of chitosan nanoparticles based dry powder inhalation formulations of prothionamide","volume":"13","author":"Debnath","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0635","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.carbpol.2018.06.034","article-title":"Genipin-crosslinked carboxymethyl chitosan nanogel for lung-targeted delivery of isoniazid and rifampin","volume":"197","author":"Wu","year":"2018","journal-title":"Carbohydr. Polym."},{"issue":"sup2","key":"10.1016\/j.ijbiomac.2022.09.116_bb0640","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1080\/21691401.2018.1463231","article-title":"Cyclosporine a\/porous quaternized chitosan microspheres as a novel pulmonary drug delivery system","volume":"46","author":"Yang","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0645","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2017.04.044","article-title":"Chitosan and hyaluronan coated liposomes for pulmonary administration of curcumin","volume":"525","author":"Manconi","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0650","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.carbpol.2017.06.090","article-title":"Microparticles prepared with 50\u2013190 kda chitosan as promising non-toxic carriers for pulmonary delivery of isoniazid","volume":"174","author":"Oliveira","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0655","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.colsurfb.2017.03.044","article-title":"Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis","volume":"154","author":"Rawal","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.09.116_bb0660","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1080\/03639045.2017.1318895","article-title":"Development of drug-loaded chitosan hollow nanoparticles for delivery of paclitaxel to human lung cancer A549 cells","volume":"43","author":"Jiang","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"7","key":"10.1016\/j.ijbiomac.2022.09.116_bb0665","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/09205063.2016.1144454","article-title":"Electrospun nanofibers of poly(\u03f5-caprolactone)\/depolymerized chitosan for respiratory tissue engineering applications","volume":"27","author":"Mahoney","year":"2016","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"11","key":"10.1016\/j.ijbiomac.2022.09.116_bb0670","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ppsc.201600123","article-title":"Nano-in-micro POxylated polyurea dendrimers and chitosan dry powder formulations for pulmonary delivery","volume":"33","author":"Restani","year":"2016","journal-title":"Part. Part. Syst. Charact."},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.09.116_bb0675","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1208\/s12249-015-0283-3","article-title":"Development of novel chitosan microcapsules for pulmonary delivery of dapsone: characterization, aerosol performance, and in vivo toxicity evaluation","volume":"16","author":"Ortiz","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0680","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijbiomac.2021.12.073","article-title":"Silymarin\/curcumin loaded albumin nanoparticles coated by chitosan as muco-inhalable delivery system observing anti-inflammatory and anti-COVID-19 characterizations in oleic acid triggered lung injury and in vitro COVID-19 experiment","volume":"198","author":"Hanafy","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"121652","key":"10.1016\/j.ijbiomac.2022.09.116_bb0685","article-title":"Synthesis and characterization of berberine-loaded chitosan nanoparticles for the protection of urethane-induced lung cancer","volume":"618","author":"Mahmoud","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.09.116_bb0690","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1208\/s12249-019-1458-0","article-title":"Alginate microspheres elicit innate m1-inflammatory response in macrophages leading to bacillary killing","volume":"20","author":"Vaghasiya","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0695","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejps.2018.06.015","article-title":"Design and characterization of emulsified spray dried alginate microparticles as a carrier for the dually acting drug roflumilast","volume":"122","author":"Mahmoud","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.09.116_bb0700","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/1120009X.2015.1105624","article-title":"Non-invasive endotracheal delivery of paclitaxel-loaded alginate microparticles","volume":"28","author":"Alipour","year":"2016","journal-title":"J. Chemother."},{"issue":"13","key":"10.1016\/j.ijbiomac.2022.09.116_bb0705","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1039\/C6TB00178E","article-title":"Preparation of nanosized coacervates of positive and negative starch derivatives intended for pulmonary delivery of proteins","volume":"4","author":"Barthold","year":"2016","journal-title":"J. Mater. Chem. B materBiol. Med."},{"issue":"118919","key":"10.1016\/j.ijbiomac.2022.09.116_bb0710","article-title":"Paclitaxel-loaded micro or nano transfersome formulation into novel tablets for pulmonary drug delivery via nebulization","volume":"575","author":"Khan","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.116_bb0715","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5487\/TR.2019.35.1.045","article-title":"Inhalation of bacterial cellulose nanofibrils triggers an inflammatory response and changes lung tissue morphology of mice","volume":"35","author":"Silva-Carvalho","year":"2019","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0720","doi-asserted-by":"crossref","first-page":"7599","DOI":"10.1007\/s13369-020-04720-2","article-title":"Evaluation of anti-inflammatory activity and in vitro drug release of ibuprofen-loaded nanoparticles based on sodium alginate and chitosan","volume":"45","author":"Bensouiki","year":"2020","journal-title":"Arab. J. Sci. Eng."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.09.116_bb0725","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1208\/s12249-018-1278-7","article-title":"Promising chitosan-coated alginate-tween 80 nanoparticles as rifampicin coadministered ascorbic acid delivery carrier against mycobacterium tuberculosis","volume":"20","author":"Scolari","year":"2019","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.09.116_bb0730","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/pharmaceutics11080379","article-title":"Alginate\/chitosan particle-based drug delivery systems for pulmonary applications","volume":"11","author":"Hill","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0735","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jddst.2019.04.002","article-title":"Development and characterization of alginate\/chitosan nanoparticulate system for hydrophobic drug encapsulation","volume":"52","author":"Nalini","year":"2019","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0740","first-page":"1","article-title":"Biodegradable AlginateChitosan hollow nanospheres for codelivery of doxorubicin and paclitaxel for the effect of human lung cancer A549 cells","volume":"2018","author":"Tao","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0745","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2018.11.070","article-title":"Optimization and in-vitro\/in-vivo evaluation of doxorubicin-loaded chitosan-alginate nanoparticles using a melanoma mouse model","volume":"556","author":"Yoncheva","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0750","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ijbiomac.2017.05.062","article-title":"Valuation of biocompatibility and antioxidant efficiency of chitosanalginate nanoparticles loaded with quercetin","volume":"103","author":"Aluani","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0755","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jddst.2017.04.034","article-title":"Carrageenanstabilized chitosan alginate nanoparticles loaded with ethionamide for the treatment of tuberculosis","volume":"39","author":"Abdelghany","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0760","first-page":"1","article-title":"Chitosanalginate nanoparticle system efficiently delivers doxorubicin to MCF-7 cells","volume":"2016","author":"Katuwavila","year":"2016","journal-title":"J. Nanomater."},{"key":"10.1016\/j.ijbiomac.2022.09.116_bb0765","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3762\/bjnano.7.112","article-title":"Preparation of alginate-chitosan-cyclodextrin micro- and nanoparticles loaded with anti-tuberculosis compounds","volume":"7","author":"Ivancic","year":"2016","journal-title":"Beilstein J. Nanotechnol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.09.116_bb0770","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/cbdd.12771","article-title":"Novel alginate-chitosan composite microspheres for implant delivery of vancomycin and in vivo evaluation","volume":"88","author":"Mao","year":"2016","journal-title":"Chem. Biol. Drug Des."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022020487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022020487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:56:26Z","timestamp":1758880586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813022020487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":154,"alternative-id":["S0141813022020487"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.09.116","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary drug delivery applications of natural polysaccharide polymer derived nano\/micro-carrier systems: A review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.09.116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}